Acorah Software Products - Accounts Production 15.0.600 false true 31 July 2023 1 August 2022 false 1 August 2023 31 July 2024 31 July 2024 06407717 Ms Adebimpe Joseph iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 06407717 2023-07-31 06407717 2024-07-31 06407717 2023-08-01 2024-07-31 06407717 frs-core:PlantMachinery 2024-07-31 06407717 frs-core:PlantMachinery 2023-08-01 2024-07-31 06407717 frs-core:PlantMachinery 2023-07-31 06407717 frs-core:ShareCapital 2024-07-31 06407717 frs-core:RetainedEarningsAccumulatedLosses 2024-07-31 06407717 frs-bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 06407717 frs-bus:FilletedAccounts 2023-08-01 2024-07-31 06407717 frs-bus:SmallEntities 2023-08-01 2024-07-31 06407717 frs-bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 06407717 frs-bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 06407717 frs-bus:Director1 2023-08-01 2024-07-31 06407717 frs-countries:EnglandWales 2023-08-01 2024-07-31 06407717 2022-07-31 06407717 2023-07-31 06407717 2022-08-01 2023-07-31 06407717 frs-core:CurrentFinancialInstruments 2023-07-31 06407717 frs-core:ShareCapital 2023-07-31 06407717 frs-core:RetainedEarningsAccumulatedLosses 2023-07-31
Registered number: 06407717
Amity Pharma Limited
Unaudited Financial Statements
For The Year Ended 31 July 2024
Keystride Consulting
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 06407717
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 1,753 2,337
1,753 2,337
CURRENT ASSETS
Debtors 5 - 4,749
Cash at bank and in hand 17,529 22,148
17,529 26,897
NET CURRENT ASSETS (LIABILITIES) 17,529 26,897
TOTAL ASSETS LESS CURRENT LIABILITIES 19,282 29,234
NET ASSETS 19,282 29,234
CAPITAL AND RESERVES
Called up share capital 6 100 100
Profit and Loss Account 19,182 29,134
SHAREHOLDERS' FUNDS 19,282 29,234
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Ms Adebimpe Joseph
Director
10/10/2024
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Amity Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 06407717 . The registered office is 10 Dragons Way, Barnet, EN5 2FL.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Equipment 25% on a reducing balance basis
Plant & Machinery 14618
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
4. Tangible Assets
Plant & Machinery
£
Cost
As at 1 August 2023 14,618
As at 31 July 2024 14,618
Depreciation
As at 1 August 2023 12,281
Provided during the period 584
As at 31 July 2024 12,865
Net Book Value
As at 31 July 2024 1,753
As at 1 August 2023 2,337
5. Debtors
2024 2023
£ £
Due within one year
Other debtors - 4,749
6. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 100 100
Page 2